home / stock / wxibf / wxibf quote
Last: | $1.68 |
---|---|
Change Percent: | 0.0% |
Open: | $1.68 |
Close: | $1.68 |
High: | $1.68 |
Low: | $1.68 |
Volume: | 8,890 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.68 | $1.68 | $1.68 | $1.68 | $1.68 | 8,890 | 04-26-2024 |
$1.645 | $1.645 | $1.645 | $1.645 | $1.645 | 65,500 | 04-24-2024 |
$1.695 | $0 | $1.695 | $0 | $0 | 10,500 | 04-19-2024 |
$1.695 | $1.695 | $1.695 | $1.695 | $1.695 | 9,400 | 04-18-2024 |
$1.7 | $1.7 | $1.7 | $1.7 | $1.7 | 3,300 | 04-16-2024 |
$1.702 | $1.702 | $1.702 | $1.702 | $1.702 | 100 | 04-15-2024 |
$1.81 | $1.81 | $1.81 | $1.81 | $1.81 | 175 | 04-10-2024 |
$1.67 | $0 | $1.67 | $0 | $0 | 50,000 | 04-03-2024 |
$1.67 | $1.67 | $1.67 | $1.67 | $1.67 | 859 | 04-02-2024 |
$1.85 | $1.87 | $1.85 | $1.87 | $1.85 | 8,500 | 04-01-2024 |
$1.9 | $1.845 | $1.9 | $1.9 | $1.845 | 835,800 | 03-29-2024 |
$1.9 | $1.845 | $1.9 | $1.9 | $1.845 | 835,800 | 03-28-2024 |
$1.735 | $0 | $1.735 | $0 | $0 | 200,000 | 03-27-2024 |
$1.735 | $1.735 | $1.735 | $1.735 | $1.735 | 210 | 03-26-2024 |
$1.8 | $1.8 | $1.8 | $1.8 | $1.8 | 480 | 03-22-2024 |
$1.85 | $1.85 | $1.85 | $1.85 | $1.85 | 211,010 | 03-21-2024 |
$1.87 | $1.785 | $1.87 | $1.87 | $1.785 | 168,201 | 03-20-2024 |
$2.44 | $0 | $2.44 | $0 | $0 | 50,000 | 03-19-2024 |
$2.44 | $0 | $2.44 | $0 | $0 | 50,000 | 03-15-2024 |
$2.44 | $0 | $2.44 | $0 | $0 | 120 | 03-14-2024 |
News, Short Squeeze, Breakout and More Instantly...
Wuxi Biologics Cayman Inc Company Name:
WXIBF Stock Symbol:
OTCMKTS Market:
U.S. intelligence officials have informed senators that WuXi AppTec Co Ltd (OTC:WXIBF), a Chinese pharmaceutical company, allegedly transferred U.S...
The pharmaceutical market reached a total value of US$1.27 trillion in 2020, according to data from Statista , up significantly from US$887 billion in 2010. By 2025, that value is expected to increase even further to an estimated US$1.6 billion. Experienced and novice invest...
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures NEW JERSEY and HANGZHOU, CHINA, July 15, 2021 - (ACN Newswire) - Adlai Nortye Ltd. (hereinafter referred to as "...